Attitude towards cholera vaccination and its related factors in Jordan amid the 2022 Middle East outbreak.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
16 Aug 2024
Historique:
received: 06 02 2024
accepted: 12 08 2024
medline: 17 8 2024
pubmed: 17 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

An outbreak of cholera was reported in the Middle East by the second half of 2022. Raising public awareness and vaccination against cholera represent critical factors in the preventive efforts. The current study aimed to assess the knowledge of cholera and attitude towards its vaccination among a sample of the general public residing in Jordan. An online self-administered questionnaire was distributed to the residents in Jordan using a snowball convenience-based sampling approach. The questionnaire based on previously published studies included items to evaluate sociodemographic variables, knowledge about cholera symptoms, transmission, and prevention and the willingness to accept cholera vaccination. Additionally, four items based on the validated 5 C scale in Arabic were included to assess the psychological factors influencing attitude to cholera vaccination. The final study sample comprised 1339 respondents, of whom 1216 (90.8%) heard of cholera before the study. Among those who heard of cholera, and on a scale from 0 to 20, the overall mean cholera Knowledge score (K-score) was 12.9 ± 3.8. In multivariate analysis, being over 30 years old and occupation as healthcare workers or students in healthcare-related colleges were significantly associated with a higher K-score compared to younger individuals and students in non-healthcare-related colleges. Overall, the acceptance of cholera vaccination if cases are recorded in Jordan, and if the vaccine is safe, effective, and provided freely was reported among 842 participants (69.2%), while 253 participants were hesitant (20.8%) and 121 participants were resistant (10.0%). In linear regression, the significant predictors of cholera vaccine acceptance were solely the three psychological factors namely high confidence, low constraints, and high collective responsibility. In this study, the identified gaps in cholera knowledge emphasize the need to enhance educational initiatives. Although cholera vaccine acceptance was relatively high, a significant minority of the respondents exhibited vaccination hesitancy or resistance. The evident correlation between the psychological determinants and attitudes toward cholera vaccination emphasizes the need to consider these factors upon designing public health campaigns aimed at cholera prevention. The insights of the current study highlight the importance of addressing both knowledge gaps and psychological barriers to optimize cholera control strategies.

Sections du résumé

BACKGROUND BACKGROUND
An outbreak of cholera was reported in the Middle East by the second half of 2022. Raising public awareness and vaccination against cholera represent critical factors in the preventive efforts. The current study aimed to assess the knowledge of cholera and attitude towards its vaccination among a sample of the general public residing in Jordan.
METHODS METHODS
An online self-administered questionnaire was distributed to the residents in Jordan using a snowball convenience-based sampling approach. The questionnaire based on previously published studies included items to evaluate sociodemographic variables, knowledge about cholera symptoms, transmission, and prevention and the willingness to accept cholera vaccination. Additionally, four items based on the validated 5 C scale in Arabic were included to assess the psychological factors influencing attitude to cholera vaccination.
RESULTS RESULTS
The final study sample comprised 1339 respondents, of whom 1216 (90.8%) heard of cholera before the study. Among those who heard of cholera, and on a scale from 0 to 20, the overall mean cholera Knowledge score (K-score) was 12.9 ± 3.8. In multivariate analysis, being over 30 years old and occupation as healthcare workers or students in healthcare-related colleges were significantly associated with a higher K-score compared to younger individuals and students in non-healthcare-related colleges. Overall, the acceptance of cholera vaccination if cases are recorded in Jordan, and if the vaccine is safe, effective, and provided freely was reported among 842 participants (69.2%), while 253 participants were hesitant (20.8%) and 121 participants were resistant (10.0%). In linear regression, the significant predictors of cholera vaccine acceptance were solely the three psychological factors namely high confidence, low constraints, and high collective responsibility.
CONCLUSIONS CONCLUSIONS
In this study, the identified gaps in cholera knowledge emphasize the need to enhance educational initiatives. Although cholera vaccine acceptance was relatively high, a significant minority of the respondents exhibited vaccination hesitancy or resistance. The evident correlation between the psychological determinants and attitudes toward cholera vaccination emphasizes the need to consider these factors upon designing public health campaigns aimed at cholera prevention. The insights of the current study highlight the importance of addressing both knowledge gaps and psychological barriers to optimize cholera control strategies.

Identifiants

pubmed: 39152391
doi: 10.1186/s12889-024-19768-0
pii: 10.1186/s12889-024-19768-0
doi:

Substances chimiques

Cholera Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2237

Informations de copyright

© 2024. The Author(s).

Références

Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. Cholera. Lancet. 2017;390(10101):1539–49. https://doi.org/10.1016/s0140-6736(17)30559-7 .
doi: 10.1016/s0140-6736(17)30559-7 pubmed: 28302312
Cholera - Key facts [ https://www.who.int/news-room/fact-sheets/detail/cholera. ]
Lippi D, Gotuzzo E, Caini S, Cholera. Microbiol Spectr. 2016;4(4). https://doi.org/10.1128/microbiolspec.PoH-0012-2015 .
Nair GB, Narain JP. From endotoxin to exotoxin: De’s rich legacy to cholera. Bull World Health Organ. 2010;88(3):237–40. https://doi.org/10.2471/blt.09.072504 .
doi: 10.2471/blt.09.072504 pubmed: 20428396 pmcid: 2828792
Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012;379(9835):2466–76. https://doi.org/10.1016/s0140-6736(12)60436-x .
doi: 10.1016/s0140-6736(12)60436-x pubmed: 22748592 pmcid: 3761070
Harris JB, LaRocque RC, Chowdhury F, Khan AI, Logvinenko T, Faruque AS, Ryan ET, Qadri F, Calderwood SB. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis. 2008;2(4):e221. https://doi.org/10.1371/journal.pntd.0000221 .
doi: 10.1371/journal.pntd.0000221 pubmed: 18398491 pmcid: 2271133
Deen JL, von Seidlein L, Sur D, Agtini M, Lucas ME, Lopez AL, Kim DR, Ali M, Clemens JD. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis. 2008;2(2):e173. https://doi.org/10.1371/journal.pntd.0000173 .
doi: 10.1371/journal.pntd.0000173 pubmed: 18299707 pmcid: 2254203
Montero DA, Vidal RM, Velasco J, George S, Lucero Y, Gómez LA, Carreño LJ, García-Betancourt R, O’Ryan M. Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development. Front Med (Lausanne). 2023;10:1155751. https://doi.org/10.3389/fmed.2023.1155751 .
doi: 10.3389/fmed.2023.1155751 pubmed: 37215733
Kwesiga B, Pande G, Ario AR, Tumwesigye NM, Matovu JKB, Zhu BP. A prolonged, community-wide cholera outbreak associated with drinking water contaminated by sewage in Kasese District, western Uganda. BMC Public Health. 2017;18(1):30. https://doi.org/10.1186/s12889-017-4589-9 .
doi: 10.1186/s12889-017-4589-9 pubmed: 28720083 pmcid: 5516304
Kanungo S, Azman AS, Ramamurthy T, Deen J, Dutta S. Cholera. Lancet. 2022;399(10333):1429–40. https://doi.org/10.1016/s0140-6736(22)00330-0 .
doi: 10.1016/s0140-6736(22)00330-0 pubmed: 35397865
Taylor DL, Kahawita TM, Cairncross S, Ensink JH. The impact of Water, Sanitation and Hygiene interventions to control Cholera: a systematic review. PLoS ONE. 2015;10(8):e0135676. https://doi.org/10.1371/journal.pone.0135676 .
doi: 10.1371/journal.pone.0135676 pubmed: 26284367 pmcid: 4540465
Buliva E, Elnossery S, Okwarah P, Tayyab M, Brennan R, Abubakar A. Cholera prevention, control strategies, challenges and World Health Organization initiatives in the Eastern Mediterranean Region: a narrative review. Heliyon. 2023;9(5):e15598. https://doi.org/10.1016/j.heliyon.2023.e15598 .
doi: 10.1016/j.heliyon.2023.e15598 pubmed: 37153427 pmcid: 10160509
Baličević SA, Elimian KO, King C, Diaconu K, Akande OW, Ihekweazu V, Trolle H, Gaudenzi G, Forsberg B, Alfven T. Influences of community engagement and health system strengthening for cholera control in cholera reporting countries. BMJ Glob Health. 2023;8(12). https://doi.org/10.1136/bmjgh-2023-013788 .
Bellizzi S, Pichierri G, Cegolon L, Panu Napodano CM, Ali Maher O. Coordination during Cholera Outbreak response: critical insights from Yemen. Am J Trop Med Hyg. 2021;105(5):1155–6. https://doi.org/10.4269/ajtmh.21-0128 .
doi: 10.4269/ajtmh.21-0128 pubmed: 34398816 pmcid: 8592192
Elimian K, Musah A, Dewa O, King C, Crawford K, Pembi E, Ike I, Myles P, Pritchard C, Forsberg BC, et al. Resource availability and capacity to implement multi-stranded cholera interventions in the north-east region of Nigeria. BMC Global Public Health. 2023;1(1):6. https://doi.org/10.1186/s44263-023-00008-3 .
doi: 10.1186/s44263-023-00008-3
Olatunji G, Kokori E, Moradeyo A, Olatunji D, Ajibola F, Otolorin O, Aderinto N. A perspective on the 2023 Cholera outbreaks in Zimbabwe: implications, response strategies, and Policy recommendations. J Epidemiol Global Health. 2023. https://doi.org/10.1007/s44197-023-00165-6 .
doi: 10.1007/s44197-023-00165-6
Popescu C, Mousa AB, Bellizzi S, Ali M, Alhawarat MN, Alsawalha L, Hussainat M, El-Alam R, Shakkour M, Al-Qutob R, et al. Risk as catalyst for positive change: lessons learnt from public health readiness for cholera in Jordan. BMJ Glob Health. 2023;8(9). https://doi.org/10.1136/bmjgh-2023-012282 .
Ganesan D, Gupta SS, Legros D. Cholera surveillance and estimation of burden of cholera. Vaccine. 2020;38(Suppl 1):A13–7. https://doi.org/10.1016/j.vaccine.2019.07.036 .
doi: 10.1016/j.vaccine.2019.07.036 pubmed: 31326254
Debes AK, Ateudjieu J, Guenou E, Ebile W, Sonkoua IT, Njimbia AC, Steinwald P, Ram M, Sack DA. Clinical and Environmental Surveillance for Vibrio cholerae in Resource constrained areas: application during a 1-Year surveillance in the Far North Region of Cameroon. Am J Trop Med Hyg. 2016;94(3):537–43. https://doi.org/10.4269/ajtmh.15-0496 .
doi: 10.4269/ajtmh.15-0496 pubmed: 26755564 pmcid: 4775888
Pezzoli L. Global oral cholera vaccine use, 2013–2018. Vaccine. 2020;38(Suppl 1):A132–40. https://doi.org/10.1016/j.vaccine.2019.08.086 .
doi: 10.1016/j.vaccine.2019.08.086 pubmed: 31519444
Cholera vaccines. WHO position paper–August 2017–Vaccins anticholériques: Note de synthèse de l’OMS–août 2017 [ https://www.who.int/publications/i/item/who-wer9234-477-500 ]
Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, Qadri F, Digilio L, Sack DA, Ali M, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(10):1080–8. https://doi.org/10.1016/s1473-3099(17)30359-6 .
doi: 10.1016/s1473-3099(17)30359-6 pubmed: 28729167 pmcid: 5639147
Song KR, Lim JK, Park SE, Saluja T, Cho SI, Wartel TA, Lynch J. Oral Cholera Vaccine Efficacy and Effectiveness. Vaccines (Basel). 2021;9(12):1482. https://doi.org/10.3390/vaccines9121482 .
doi: 10.3390/vaccines9121482 pubmed: 34960228 pmcid: 8708586
Démolis R, Botão C, Heyerdahl LW, Gessner BD, Cavailler P, Sinai C, Magaço A, Le Gargasson JB, Mengel M, Guillermet E. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique. Vaccine. 2018;36(44):6497–505. https://doi.org/10.1016/j.vaccine.2017.10.087 .
doi: 10.1016/j.vaccine.2017.10.087 pubmed: 29174106 pmcid: 6190029
Kar SK, Pach A, Sah B, Kerketta AS, Patnaik B, Mogasale V, Kim YH, Rath SB, Shin S, Khuntia HK, et al. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India. Hum Vaccin Immunother. 2014;10(10):2834–42. https://doi.org/10.4161/21645515.2014.971655 .
doi: 10.4161/21645515.2014.971655 pubmed: 25483631 pmcid: 5443101
Trolle H, Forsberg B, King C, Akande O, Ayres S, Alfvén T, Elimian K. A scoping review of facilitators and barriers influencing the implementation of surveillance and oral cholera vaccine interventions for cholera control in lower- and middle-income countries. BMC Public Health. 2023;23(1):455. https://doi.org/10.1186/s12889-023-15326-2 .
doi: 10.1186/s12889-023-15326-2 pubmed: 36890476 pmcid: 9994404
Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: development of a measure assessing the 5 C psychological antecedents of vaccination. PLoS ONE. 2018;13(12):e0208601. https://doi.org/10.1371/journal.pone.0208601 .
doi: 10.1371/journal.pone.0208601 pubmed: 30532274 pmcid: 6285469
Betsch C, Bach Habersaat K, Deshevoi S, Heinemeier D, Briko N, Kostenko N, Kocik J, Böhm R, Zettler I, Wiysonge CS, et al. Sample study protocol for adapting and translating the 5 C scale to assess the psychological antecedents of vaccination. BMJ Open. 2020;10(3):e034869. https://doi.org/10.1136/bmjopen-2019-034869 .
doi: 10.1136/bmjopen-2019-034869 pubmed: 32161160 pmcid: 7066639
Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of Influenza Vaccination Intention and behavior - A systematic review of Influenza Vaccine Hesitancy, 2005–2016. PLoS ONE. 2017;12(1):e0170550. https://doi.org/10.1371/journal.pone.0170550 .
doi: 10.1371/journal.pone.0170550 pubmed: 28125629 pmcid: 5268454
Mahameed H, Al-Mahzoum K, AlRaie LA, Aburumman R, Al-Naimat H, Alhiary S, Barakat M, Al-Tammemi AB, Salim NA, Sallam M. Previous vaccination history and psychological factors as significant predictors of willingness to Receive Mpox Vaccination and a favorable attitude towards compulsory vaccination. Vaccines (Basel). 2023;11(5):897. https://doi.org/10.3390/vaccines11050897 .
doi: 10.3390/vaccines11050897 pubmed: 37243001
Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting Psychological Science Into Action. Psychol Sci Public Interest. 2017;18(3):149–207. https://doi.org/10.1177/1529100618760521 .
doi: 10.1177/1529100618760521 pubmed: 29611455
Sallam M, Ghazy RM, Al-Salahat K, Al-Mahzoum K, AlHadidi NM, Eid H, Kareem N, Al-Ajlouni E, Batarseh R, Ababneh NA, et al. The role of psychological factors and Vaccine Conspiracy beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 pandemic. Vaccines (Basel). 2022;10(8):1355. https://doi.org/10.3390/vaccines10081355 .
doi: 10.3390/vaccines10081355 pubmed: 36016243
Lam E, Al-Tamimi W, Russell SP, Butt MO, Blanton C, Musani AS, Date K. Oral Cholera Vaccine Coverage during an outbreak and Humanitarian Crisis, Iraq, 2015. Emerg Infect Dis. 2017;23(1):38–45. https://doi.org/10.3201/eid2301.160881 .
doi: 10.3201/eid2301.160881 pubmed: 27983502 pmcid: 5176248
Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2015;2(1):61–73. https://doi.org/10.1177/2372732215600716 .
doi: 10.1177/2372732215600716
Deen J, Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine. 2020;38:A31–40. https://doi.org/10.1016/j.vaccine.2019.07.078 .
doi: 10.1016/j.vaccine.2019.07.078 pubmed: 31395455
Ilic I, Ilic M. Global patterns of trends in Cholera Mortality. Trop Med Infect Dis. 2023;8(3):169. https://doi.org/10.3390/tropicalmed8030169 .
doi: 10.3390/tropicalmed8030169 pubmed: 36977170 pmcid: 10058923
Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9(6):e0003832. https://doi.org/10.1371/journal.pntd.0003832 .
doi: 10.1371/journal.pntd.0003832 pubmed: 26043000 pmcid: 4455997
Ali M, Lopez AL, You YA, Kim YE, Sah B, Maskery B, Clemens J. The global burden of cholera. Bull World Health Organ. 2012;90(3):209–a218. https://doi.org/10.2471/blt.11.093427 .
doi: 10.2471/blt.11.093427 pubmed: 22461716 pmcid: 3314202
Topluoglu S, Taylan-Ozkan A, Alp E. Impact of wars and natural disasters on emerging and re-emerging infectious diseases. Front Public Health. 2023;11:1215929. https://doi.org/10.3389/fpubh.2023.1215929 .
doi: 10.3389/fpubh.2023.1215929 pubmed: 37727613 pmcid: 10505936
Centers for Disease Control and Prevention (CDC). Cholera epidemic after increased civil conflict–Monrovia, Liberia, June-September 2003. MMWR Morb Mortal Wkly Rep. 2003;52(45):1093–5.
Shannon K, Hast M, Azman AS, Legros D, McKay H, Lessler J. Cholera prevention and control in refugee settings: successes and continued challenges. PLoS Negl Trop Dis. 2019;13(6):e0007347. https://doi.org/10.1371/journal.pntd.0007347 .
doi: 10.1371/journal.pntd.0007347 pubmed: 31220084 pmcid: 6586254
Federspiel F, Ali M. The cholera outbreak in Yemen: lessons learned and way forward. BMC Public Health. 2018;18(1):1338. https://doi.org/10.1186/s12889-018-6227-6 .
doi: 10.1186/s12889-018-6227-6 pubmed: 30514336 pmcid: 6278080
Berjaoui C, Akoum NA, El Nouiri A, Khayat S, Abbass M, Mousawi AA, Wellington J, Uwishema O. A minireview of cholera outbreak in Lebanon - a rising public health concern. Ann Med Surg (Lond). 2023;85(4):879–83. https://doi.org/10.1097/ms9.0000000000000293 .
doi: 10.1097/ms9.0000000000000293 pubmed: 37113821
Al-Tammemi AB, Sallam M. The current cholera menace amid the war crisis in Syria and the economic crisis in Lebanon: a time for global solidarity. New Microbes New Infect. 2023;51:101069. https://doi.org/10.1016/j.nmni.2022.101069 .
doi: 10.1016/j.nmni.2022.101069 pubmed: 36593883
Burnett E, Dalipanda T, Ogaoga D, Gaiofa J, Jilini G, Halpin A, Dietz V, Date K, Mintz E, Hyde T, et al. Knowledge, attitudes, and practices regarding Diarrhea and Cholera following an oral cholera vaccination campaign in the Solomon Islands. PLoS Negl Trop Dis. 2016;10(8):e0004937. https://doi.org/10.1371/journal.pntd.0004937 .
doi: 10.1371/journal.pntd.0004937 pubmed: 27548678 pmcid: 4993445
Ali EM, Mohamed MB, Tawhari M. Knowledge, attitude, and practice study regarding cholera among the people in Jazan City, KSA. J Family Med Prim Care. 2021;10(2):712–7. https://doi.org/10.4103/jfmpc.jfmpc_965_20 .
doi: 10.4103/jfmpc.jfmpc_965_20 pubmed: 34041066 pmcid: 8138396
Akel M, Sakr F, Haddad C, Hajj A, Sacre H, Zeenny RM, Safwan J, Salameh P. Knowledge, attitude, and practices of the General Population toward the Old-New Outbreak of Cholera in a developing country. Trop Med Infect Dis. 2023;8(4):236. https://doi.org/10.3390/tropicalmed8040236 .
doi: 10.3390/tropicalmed8040236 pubmed: 37104361 pmcid: 10144007
Orimbo EO, Oyugi E, Dulacha D, Obonyo M, Hussein A, Githuku J, Owiny M, Gura Z. Knowledge, attitude and practices on cholera in an arid county, Kenya, 2018: a mixed-methods approach. PLoS ONE. 2020;15(2):e0229437. https://doi.org/10.1371/journal.pone.0229437 .
doi: 10.1371/journal.pone.0229437 pubmed: 32101587 pmcid: 7043758
Knowledge attitudes. and practices (KAP) surveys during cholera vaccination campaigns: guidance for Oral Cholera Vaccine Stockpile Campaigns [ https://www.who.int/publications/m/item/knowledge-attitudes-and-practices-(kap)-surveys-during-cholera-vaccination-campaigns-guidance-for-oral-cholera-vaccine-stockpile-campaigns ]
Sallam M, Al-Sanafi M, Sallam M. A Global Map of COVID-19 Vaccine Acceptance Rates per Country: an updated Concise Narrative Review. J Multidiscip Healthc. 2022;15:21–45. https://doi.org/10.2147/jmdh.S347669 .
doi: 10.2147/jmdh.S347669 pubmed: 35046661 pmcid: 8760993
Barakat M, Abdaljaleel M, Atawneh N, Alkhazaleh R, Aburumman D, Hamed E, Sallam M. Pervasive parental hesitancy and resistance towards Measles Rubella Vaccination in Jordan. Vaccines (Basel). 2023;11(11):1672. https://doi.org/10.3390/vaccines11111672 .
doi: 10.3390/vaccines11111672 pubmed: 38006004
Alsanafi M, Salim NA, Sallam M. Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs. Hum Vaccin Immunother. 2023;19(1):2194772. https://doi.org/10.1080/21645515.2023.2194772 .
doi: 10.1080/21645515.2023.2194772 pubmed: 37005342 pmcid: 10088927
Malaeb D, Sallam M, Younes S, Mourad N, Sarray El Dine A, Obeid S, Hallit S, Hallit R. Knowledge, attitude, and practice in a sample of the Lebanese Population regarding Cholera. Int J Environ Res Public Health. 2022;19(23):16243. https://doi.org/10.3390/ijerph192316243 .
doi: 10.3390/ijerph192316243 pubmed: 36498316 pmcid: 9735709
Abd ElHafeez S, Elbarazi I, Shaaban R, ElMakhzangy R, Ossama Aly M, Alnagar A, Yacoub M, El Saeh HM, Eltaweel N, Alqutub ST, et al. Arabic validation and cross-cultural adaptation of the 5 C scale for assessment of COVID-19 vaccines psychological antecedents. PLoS ONE. 2021;16(8):e0254595. https://doi.org/10.1371/journal.pone.0254595 .
doi: 10.1371/journal.pone.0254595 pubmed: 34437554 pmcid: 8389382
Sample size to. Estimate a proportion or apparent prevalence with specified precision [ https://epitools.ausvet.com.au/oneproportion ]
Population. [ https://dosweb.dos.gov.jo/population/population-2/ ]
Al Sa’ady AT. Iraq faces new outbreak of cholera, 2022. Germs. 2023;13(1):90–1. https://doi.org/10.18683/germs.2023.1372 .
doi: 10.18683/germs.2023.1372 pubmed: 38023958 pmcid: 10659750
Eneh SC, Admad S, Nazir A, Onukansi FO, Oluwatobi A, Innocent DC, Ojo TO. Cholera outbreak in Syria amid humanitarian crisis: the epidemic threat, future health implications, and response strategy - a review. Front Public Health. 2023;11:1161936. https://doi.org/10.3389/fpubh.2023.1161936 .
doi: 10.3389/fpubh.2023.1161936 pubmed: 37408746 pmcid: 10319003
Alhaffar MHDBA, Gomez MMM, Sigua JA, Eriksson A. The cholera outbreak in Syria: a call for urgent actions. IJID Reg. 2023;8:71–4. https://doi.org/10.1016/j.ijregi.2023.06.005 .
doi: 10.1016/j.ijregi.2023.06.005 pubmed: 37521106 pmcid: 10372181
Helou M, Khalil M, Husni R. The Cholera Outbreak in Lebanon: October 2022. Disaster Med Public Health Prep. 2023;17:e422. https://doi.org/10.1017/dmp.2023.76 .
doi: 10.1017/dmp.2023.76 pubmed: 37381669
Al-Sakkaf K, Bahattab A, Basaleem H. Cholera knowledge, socioeconomic and WaSH characteristics in Aden - Yemen, 2017: a community-based comparative survey. J Prev Med Hyg. 2020;61(3):E392–400. https://doi.org/10.15167/2421-4248/jpmh2020.61.3.1529 .
doi: 10.15167/2421-4248/jpmh2020.61.3.1529 pubmed: 33150228 pmcid: 7595064
Chae SR, Lukupulo H, Kim S, Walker T, Hardy C, Abade A, Urio LJ, Mghamba J, Quick R. An Assessment of Household Knowledge and practices during a Cholera Epidemic- Dar es Salaam, Tanzania, 2016. Am J Trop Med Hyg. 2022;107(4):766–72. https://doi.org/10.4269/ajtmh.21-0597 .
doi: 10.4269/ajtmh.21-0597 pubmed: 36067990 pmcid: 9651532
Wahed T, Kaukab SS, Saha NC, Khan IA, Khanam F, Chowdhury F, Saha A, Khan AI, Siddik AU, Cravioto A, et al. Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh. BMC Public Health. 2013;13:242. https://doi.org/10.1186/1471-2458-13-242 .
doi: 10.1186/1471-2458-13-242 pubmed: 23509860 pmcid: 3608226
Elimian K, King C, Dewa O, Pembi E, Gandi B, Yennan S, Myles P, Pritchard C, Forsberg BC, Alfvén T. Healthcare workers knowledge of cholera multi-stranded interventions and its determining factors in North-East Nigeria: planning and policy implications. Hum Resour Health. 2023;21(1):6. https://doi.org/10.1186/s12960-023-00796-7 .
doi: 10.1186/s12960-023-00796-7 pubmed: 36726147 pmcid: 9891191
Graveleau J, Reserva ME, Keita A, Molinari R, Constantin De Magny G. Influence of Community-Led Total Sanitation and Water Coverages in the Control of Cholera in Madarounfa, Niger (2018). Front Public Health 2021, 9:643079. https://doi.org/10.3389/fpubh.2021.643079
CHOLERA IN 1979 = LE CHOLÉRA EN. 1979 [ https://iris.who.int/bitstream/handle/10665/223030/WER5518_129-130_cholera%20en%201979.PDF ]
Merten S, Schaetti C, Manianga C, Lapika B, Chaignat C-L, Hutubessy R, Weiss MG. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo. BMC Public Health. 2013;13(1):60. https://doi.org/10.1186/1471-2458-13-60 .
doi: 10.1186/1471-2458-13-60 pubmed: 23339647 pmcid: 3626893
Jamaleddine Y, Tashjian H, Mahmoud M, Azzam W, Daher A, Salameh P. Lebanese Population Knowledge, attitudes, and practice regarding Cholera Disease and their knowledge and attitude regarding the Cholera Vaccine following an outbreak in Lebanon. Res Square. 2023. https://doi.org/10.21203/rs.3.rs-2480449/v1 .
doi: 10.21203/rs.3.rs-2480449/v1
Sundaram N, Schaetti C, Merten S, Schindler C, Ali SM, Nyambedha EO, Lapika B, Chaignat C-L, Hutubessy R, Weiss MG. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach. BMC Public Health. 2016;16(1):36. https://doi.org/10.1186/s12889-016-2710-0 .
doi: 10.1186/s12889-016-2710-0 pubmed: 26762151 pmcid: 4712562
Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A. High rates of COVID-19 vaccine hesitancy and its Association with Conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines (Basel). 2021;9(1):42. https://doi.org/10.3390/vaccines9010042 .
doi: 10.3390/vaccines9010042 pubmed: 33445581
Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–9. https://doi.org/10.1016/j.vaccine.2014.01.081 .
doi: 10.1016/j.vaccine.2014.01.081 pubmed: 24598724
Larson HJ, Gakidou E, Murray CJL. The vaccine-hesitant moment. N Engl J Med. 2022;387(1):58–65. https://doi.org/10.1056/NEJMra2106441 .
doi: 10.1056/NEJMra2106441 pubmed: 35767527
Al-Sanafi M, Sallam M. Psychological determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: a cross-sectional study using the 5 C and vaccine conspiracy beliefs scales. Vaccines (Basel). 2021;9(7):701. https://doi.org/10.3390/vaccines9070701 .
doi: 10.3390/vaccines9070701 pubmed: 34202298
Ghazy RM, Okeh DU, Sallam M, Hussein M, Ismail HM, Yazbek S, Mahboob A, Abd ElHafeez S. Psychological antecedents of Healthcare Workers towards Monkeypox Vaccination in Nigeria. Vaccines (Basel). 2022;10(12):2151. https://doi.org/10.3390/vaccines10122151 .
doi: 10.3390/vaccines10122151 pubmed: 36560561

Auteurs

Malik Sallam (M)

Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan. malik.sallam@ju.edu.jo.
Department of Clinical Laboratories and Forensic Medicine, University Hospital, Queen Rania Al-Abdullah Street-Aljubeiha, P.O. Box: 13046, Amman, Jordan. malik.sallam@ju.edu.jo.

Rabaa Y Athamneh (RY)

Department of Medical Laboratories Sciences, Faculty of Allied Medical Sciences, Zarqa University, Zarqa, Jordan.

Rawan Alkhazaleh (R)

School of Medicine, The University of Jordan, Amman, Jordan.

Lana Alzayadneh (L)

School of Medicine, The University of Jordan, Amman, Jordan.

Laila Jaradat (L)

School of Medicine, The University of Jordan, Amman, Jordan.

Tala Majali (T)

School of Medicine, The University of Jordan, Amman, Jordan.

Sarah Obeidat (S)

School of Medicine, The University of Jordan, Amman, Jordan.

Aseel Shhab (A)

School of Medicine, The University of Jordan, Amman, Jordan.

Souheil Hallit (S)

School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Research Department, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon.

Muna Barakat (M)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Azmi Mahafzah (A)

Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH